F 0552 -Trazodone 50 milligrams, give 0.5 tablet by mouth at bedtime related to major depressive disorder. Start date 6/29/23. Level of Harm - Minimal harm or potential for actual harm A review of the May 2025 Medication Administration Record (MAR) indicated that Risperidone and Trazadone was administered as ordered. Residents Affected - Few Further review of the medical record indicated psychotropic informed consent forms indicating the following:
-Trazadone-signed and dated by Resident #22 on 9/18/24.
-Risperidone-signed and dated by Resident #22 on 7/10/24.
During an interview and record review on 5/21/25 at 9:52 A.M., Unit Manager #1 said Resident #22 signed
the Trazadone and Risperidone psychotropic consent forms. Unit Manager #1 said Resident #22 has an invoked HCP. Unit Manager #1 said the HCP should have been informed of the psychotropic medications
the Resident was taking so he/she could provide consent to continue to administer the psychotropic medications.
During an interview on 5/21/25 at 10:11 A.M., the Social Worker said Resident #22's HCP should have provided consent prior to the administration of the psychotropic medications. The Social Worker said she just informed the HCP about the Resident taking psychotropic medications and the need to obtain consent from him/her.
During an interview on 5/21/25 at 10:59 A.M., the Director of Nurses (DON) said residents' responsible parties should be informed of the residents' treatment and care. The DON said the HCP should have been informed of the facility administering psychotropic medications prior to administering the medications so he/she could provide consent.
During a telephone interview on 5/23/25 at 2:02 P.M., the HCP said he/she was not aware of the specific psychotropic medications Resident #22 was taking. He/she said he/she got a call from the facility a day ago asking him/her to come into the facility to sign the psychotropic consents. The HCP said prior to that call, he/she was aware the Resident was taking medications in general, but had no knowledge of the specific psychotropic medications he/she was taking, their benefits, risks and side effects.
FORM CMS-2567 (02/99) Event ID: Facility ID: If continuation sheet Previous Versions Obsolete Page 2 of 6 225469 Department of Health & Human Services Printed: 08/26/2025 Form Approved OMB Centers for Medicare & Medicaid Services No. 0938-0391
STATEMENT OF DEFICIENCIES (X1) PROVIDER/SUPPLIER/CLIA (X2) MULTIPLE CONSTRUCTION (X3) DATE SURVEY AND PLAN OF CORRECTION IDENTIFICATION NUMBER: COMPLETED A. Building 225469 B. Wing 05/21/2025
NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE
Laurel Ridge Rehab and Skilled Care Center 174 Forest Hills Street Boston, MA 02130
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)